Blog

The United States health care system has been evolving at a rapid pace with attempts to control costs while also improving outcomes for patients. Cancer care is at the center of these debates with 15.5 million cancer survivors and per person treatment costs exceeding all other diseases. Policy and decision makers are shifting from a volume-based system to value-based care in an effort to ensure that patients are receiving high-quality care at the lowest possible price. Click here to learn more about our most recent published journal articles to delve deeper into our research into value-based care designs.

Each month, the Cancer Policy Institute profiles advocates who have been engaged in advocacy in their home state, their community, with elected officials, and more. Read on to learn more about our featured advocate for January, 2019, and her incredible advocacy resume. If you are interested in learning more about policy, advocacy, and ways to get involved, sign up to be a part of the Grassroots Network!

A new court ruling has the potential to change the future of the Affordable Care Act (ACA or Obamacare). While nothing is changing immediately, it’s important for all people, including cancer patients, survivors, and their loved ones to understand what this means for them.

As 2018 comes to a close, we take a moment to reflect on a momentous year for the Research and Training Institute (RTI).

Nutrition and its impact on health is a growing concern among adults regardless of health status. For people with cancer, eating well can be critically important during treatment and beyond. With the holidays approaching, we asked clinical nutritionist Michelle Bratton from the University of Arizona Cancer Center for some tips on eating well with cancer:

Our Way Forward was created to encourage ovarian cancer patients, their loved ones and healthcare providers to rethink how they talk about ovarian cancer.

In May of 2018, the Trump Administration committed to lowering the costs of prescription drugs and out-of-pocket spending for patients. One of the ways in which the Administration suggested meeting this goal was by changing the information available to consumers in television ads that market medications, which lead to a new rule that would require pharmaceutical companies to disclose the “list price” of drugs.

On December 5th, 2018 we presented new research findings on a study of more than 600 women with breast cancer at the San Antonio Breast Cancer Symposium in San Antonio, TX. Below is a post about the significance of these findings for women diagnosed with breast cancer and for breast cancer care providers.

Our Research and Training Institute (RTI) took front stage in sunny San Diego this week at the American Society of Hematology (ASH) Annual Meeting. Three abstracts from the RTI were accepted to the conference, each representing a separate blood cancer specialty registry from the Cancer Experience Registry^®.

The affiliate is the first CSC affiliate to be located in the state of New Hampshire.